ARTG Entry
ZYNLONTA
ARTG entry for ZYNLONTA (loncastuximab tesirine), ARTG 481165 — Product Information, dosage form, registration history. Compiled by arcimedes.
- Sponsor: Swedish Orphan Biovitrum
- Active ingredient: loncastuximab tesirine
- Therapeutic area: Oncology